KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Account Payables (2016 - 2025)

Evolent Health (EVH) has 11 years of Change in Account Payables data on record, last reported at -$14.9 million in Q4 2025.

  • For Q4 2025, Change in Account Payables fell 597.39% year-over-year to -$14.9 million; the TTM value through Dec 2025 reached $6.6 million, up 56.29%, while the annual FY2025 figure was $6.6 million, 56.29% up from the prior year.
  • Change in Account Payables reached -$14.9 million in Q4 2025 per EVH's latest filing, down from $3.3 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $16.6 million in Q3 2024 and bottomed at -$14.9 million in Q4 2025.
  • Average Change in Account Payables over 5 years is $1.2 million, with a median of $681000.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: tumbled 3288.97% in 2023, then surged 15851.92% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at -$914000.0 in 2021, then soared by 890.92% to $7.2 million in 2022, then dropped by 18.32% to $5.9 million in 2023, then plummeted by 49.4% to $3.0 million in 2024, then tumbled by 597.39% to -$14.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$14.9 million in Q4 2025, $3.3 million in Q3 2025, and $14.9 million in Q2 2025.